🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Vimla Naicker

South African Medical Research Council

ORCID: 0000-0002-5634-4668

Also affiliated with University of KwaZulu-Natal

MedicineImmunology and MicrobiologySocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study”.

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

The Lancet(2022)10.1016/s0140-6736(22)00007-1
N/A
4.4DataRank · unranked
85 citations

Nigel Garrett, Ameena Goga, Lara Fairall, Tarylee Reddy, Nonhlanhla Yende-Zuma +76 more

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial

The Lancet Infectious Diseases(2024)10.1016/s1473-3099(24)00358-x
N/A
1.3DataRank · unranked
40 citations

Kathryn Mngadi, Ludo Lavreys, Steven Nijs, Peter B. Gilbert, John Hural +60 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

EClinicalMedicine(2025)10.1016/j.eclinm.2024.103054
N/A
0.269DataRank · unranked
5 citations

Asa Tapley, Aaron Hudson, Sufia Dadabhai, Bo Zhang, Nyaradzo Mgodi +93 more

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1–2 randomized double-blind placebo-controlled trial

PLOS Global Public Health(2024)10.1371/journal.pgph.0003319
N/A
0.108DataRank · unranked
1 citations

Fatima Laher, Linda‐Gail Bekker, Kelly E. Seaton, Mary Allen, Stephen De Rosa +27 more

High Asymptomatic Carriage With the Omicron Variant in South Africa

Clinical Infectious Diseases(2022)10.1093/cid/ciac237
N/A
0DataRank · unranked
81 citations

Asa Tapley, Jessica Andriesen, Ishen Seocharan, Leigh H. Fisher, Lisa Bunts +85 more

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV

Nature Communications(2025)10.1038/s41467-025-63948-4
N/A
0DataRank · unranked
1 citations

Bo Zhang, Caroline Brackett, Peter Elyanu, Asa Tapley, Sufia Dadabhai +95 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

UNC Libraries(2025)10.17615/p4hj-9n46
N/A
0DataRank · unranked
0 citations

Jia Jin Kee, Mubiana Inambao, Essack Mitha, Dishiki Kalonji, William Brumskine +76 more